Day 6 estradiol level predicts cycle cancellation among poor responder patients undergoing in vitro fertilization - Embryo transfer cycles using a gonadotropin-releasing hormone agonist flare regimen

Journal of Assisted Reproduction and Genetics

Volumn 19, Issue 7, 2002, Pages 349-353

  Kovacs, Peter ^a   Witt, Barry R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cycle cancellation; GnRHa flare; IVF ET; Poor responder; Pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; GONADORELIN AGONIST; LEUPRORELIN; DRUG DERIVATIVE; ESTRADIOL; GONADORELIN; LHRH, ALA(6) GLY(10) ETHYLAMIDE; LHRH, ALA(6)-GLY(10)-ETHYLAMIDE-;

ADULT; ARTICLE; CLINICAL PROTOCOL; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREGNANCY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; MENSTRUAL CYCLE;

ADULT; COMPARATIVE STUDY; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; GONADORELIN; HUMAN; MENSTRUAL CYCLE; GONADOTROPIN-RELEASING HORMONE; HUMANS;

EID: 0036021455     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016014810853     Document Type: Article

References (18)

1. Cessation of gonadotropin releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders
2. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques
3. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization
4. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program
5. Gonadotropin-releasing hormone agonist use in assisted reproduction cycles: The influence of long and short regimens on pregnancy rates
6. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization
7. The gonadotropin-releasing hormone agonist stimulation test - A sensitive predictor of performance in the flare-up in vitro fertilization cycle
8. Maximizing pregnancy rates and limiting higher-order multiple conceptions by determining the optimal number of embryos to transfer based on quality
9. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization
10. Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program
11. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation
12. A protocol using a low dose of gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3
13. Ovarian reserve tests in infertility practice and normal fertile women
14. The detection of diminished ovarian reserve in infertile women
15. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation
16. Hypothalamicopituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles
17. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol
18. Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development